Woltering E A, Ellison E C, O'Dorisio T M, Sparks J, Howe B, Dyben T
J Surg Res. 1986 Jun;40(6):605-10. doi: 10.1016/0022-4804(86)90104-6.
The provocation of gastrin release by calcium or secretin is accepted as a method to differentiate the hypergastrinemia of the Zollinger-Ellison syndrome from that of other causes. We have previously shown that calcium and secretin failed to provoke gastrin release from acutely dispersed gastrinoma cells. This disparity between the in vivo and in vitro effects of these two provocative agents suggests that intermediates may be necessary for calcium- or secretin-induced gastrin release. In an acute cell dispersion, serum-free model, two gastrinomas with low levels of endogenous somatostatin (SRIF) and other peptides failed to respond to calcium or secretin provocation. Conversely, a third tumor containing high levels of endogenous SRIF-like peptides and low levels of other gut peptides did respond to calcium, but not to secretin provocation in vitro. We suggest that in vivo, SRIF modulation of gastrin release is a prerequisite for calcium-simulated gastrin secretion.
通过钙或促胰液素激发胃泌素释放被公认为是一种区分卓-艾综合征的高胃泌素血症与其他病因所致高胃泌素血症的方法。我们之前已经表明,钙和促胰液素无法促使急性分散的胃泌素瘤细胞释放胃泌素。这两种激发剂在体内和体外效应之间的差异表明,中间介质对于钙或促胰液素诱导的胃泌素释放可能是必需的。在急性细胞分散的无血清模型中,两种内源性生长抑素(SRIF)及其他肽类水平较低的胃泌素瘤对钙或促胰液素激发无反应。相反,第三个肿瘤含有高水平的内源性SRIF样肽类和低水平的其他肠道肽类,其在体外对钙有反应,但对促胰液素激发无反应。我们认为,在体内,SRIF对胃泌素释放的调节是钙刺激胃泌素分泌的前提条件。